PT370 – Prohibition, Civil Disobedience, and The Coca Leaf Cafe

Webinar – The Dark Side of Psychedelic Therapies

Psychedelic Bulletin #122: Lusaris Raises $60m to Develop 5-MeO-DMT; First Take-Home...

COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Psychedelic Research Bulletin: October 2022

BREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Considering a Career in Psychedelics? Here’s How to Get Started.

Free Webinar – NueLife: Empowering Patients with At-Home Ketamine Therapy

Apex Labs Granted Approval for North America’s First Take Home Psilocybin...

ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD’S FIRST...

Load more